RAAS and Arterial Stiffness in SCI

Sponsor
James J. Peters Veterans Affairs Medical Center (U.S. Fed)
Overall Status
Unknown status
CT.gov ID
NCT04510974
Collaborator
Kessler Foundation (Other), Seton Hall University (Other)
33
1
29.1
1.1

Study Details

Study Description

Brief Summary

The study is examining differences in central arterial stiffness, orthostatic changes in blood pressure, norepinephrine, and plasma renin in individuals with spinal cord injury compared with age-matched uninjured controls.

Condition or Disease Intervention/Treatment Phase
  • Other: Spinal Cord Injury

Detailed Description

The study is examining differences in central arterial stiffness, orthostatic changes in blood pressure, norepinephrine, and plasma renin in individuals with spinal cord injury compared with age-matched uninjured controls. Arterial stiffness and blood pressure will be collected in the laying down position. A blood sample of norepinephrine and plasma renin will also be collected. The participant will tilt to 30, 45 and 60 degrees for 10 minutes at each angel. Blood pressure and heart rate will be monitored at each angle. Another blood sample of renin and norepinephrine will be collected at the end of 10 minutes at 60 degrees.

Study Design

Study Type:
Observational
Actual Enrollment :
33 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Orthostatic Blood Pressure and Arterial Stiffness in Persons With SCI: The Effect of RAAS System
Actual Study Start Date :
Jun 30, 2018
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Cervical SCI

Ages between 21-70 years old Injured between C1-T1 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago

Other: Spinal Cord Injury
Spinal Cord Injury

Thoracic SCI

Ages between 21-70 Injured between T6-T12 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago

Other: Spinal Cord Injury
Spinal Cord Injury

Able-bodied Control

Ages between 21-70

Outcome Measures

Primary Outcome Measures

  1. Pulse wave velocity (m/s) [2 years]

    Determine relationship between arterial stiffness, blood pressure, norepinephrine, and renin responses to head-up tilt among the groups.

Secondary Outcome Measures

  1. Systolic Blood Pressure (mmHg) [2 years]

    Determine differences in blood pressure among groups

  2. Plasma renin (pg/ml) [2 years]

    Determine differences in plasma renin among the groups

  3. Norepinephrine (pg/ml) [2 years]

    Determine differences in plasma norepinephrine among the groups.

  4. Norepinephrine and Renin [2 years]

    Describe the changes in norepinephrine and renin from supine rest to 60 degree tilt

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 70 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • SCI participants:

  • injured between C1-T1 and T6-T12

  • wheelchair dependent

  • AIS classification A, B or C

  • Injured occurred more than 1 year ago

Exclusion Criteria:
  • currently have an illness or infection

  • current smoker of at least 1 year

  • controlled or uncontrolled hypertension or diabetes mellitus

  • Neurological condition other than SCI (Alzheimer's disease, dementia, stroke, multiple sclerosis, Parkinson's disease)

  • cardiovascular disease (coronary heart disease, congestive heart failure, peripheral artery disease)

Contacts and Locations

Locations

Site City State Country Postal Code
1 James J Peters VAMC Bronx New York United States 10468

Sponsors and Collaborators

  • James J. Peters Veterans Affairs Medical Center
  • Kessler Foundation
  • Seton Hall University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jill M. Wecht, Ed.D., Health Science Scientist, James J. Peters Veterans Affairs Medical Center
ClinicalTrials.gov Identifier:
NCT04510974
Other Study ID Numbers:
  • WEC-18-025
First Posted:
Aug 12, 2020
Last Update Posted:
Aug 12, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 12, 2020